Targeting EPAC1 in heart failure
Topic:
Drugs, Drug Targets
Speaker:
Doctor F. Lezoualc'h (Toulouse, FR)
Seminar Presentation
About the speaker
Doctor Frank Lezoualc'h
Institute of Cardiovascular and Metabolic Diseases, Toulouse (France)
4
presentations
0
follower
3 more presentations in this session
Cardioprotective potential of soluble CD39L3 in myocardial infarction
Speaker: Doctor G. Vilahur (Barcelona, ES)
hsa-miR-548v controls the viscoelastic properties of human cardiomyocytes and improves their relaxation rates.
Speaker: Professor J. Hulot (Paris, FR)
CD69 expression on regulatory T cells protects from immune damage after myocardial infarction
Speaker: Doctor P. Martin (Madrid, ES)
Access the full session
Novel therapeutic targets in left and right ventricular dysfunction
Speakers:
Doctor F. Lezoualc'h, Doctor G. Vilahur, Professor J. Hulot, Doctor P. Martin
About the event
HFA Winter Research Meeting on Translational Heart Failure 2025
20 January - 22 January 2025
Seminar
